secwatch.observer — SEC 8-K summary
======================================

Issuer:     Equillium, Inc. (EQ)
CIK:        0001746466
Form:       8-K
Filed at:   2022-09-26T23:59:59+00:00
Accession:  0001193125-22-251386
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Equillium files Metacrine financials and pro forma statements for pending merger
--------------------------------------------------------------------------------

- Metacrine 2021 net loss $62.2M; accumulated deficit $182.95M as of Dec 31, 2021.
- Audited financials for 2021 and 2020, plus unaudited interim statements through June 30, 2022 filed.
- Unaudited pro forma combined balance sheet as of June 30, 2022 reflects the acquisition.
- Updated risk factor disclosure filed as Exhibit 99.3 to supplement prior filings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1746466/000119312522251386/0001193125-22-251386-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1746466/000119312522251386/d382206d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-251386

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer